Research | Building the Foundation for Personalized RNA Therapeutics in Heart Disease

McGill researchers have developed a new way to study why the same heart-failure treatment can help some patients recover while others continue to worsen. The research was co-led by Diego Loggia, a D2R Scholar and PhD student in McGill's Department of Pharmacology & Therapeutics.

Nineteen Canada Research Chairs awarded to McGill

Funding backs innovative research in an array of disciplines, including health sciences, music and social work.

The Government of Canada has awarded McGill $19 million in funding to support 19 researchers through the Canada Research Chairs (CRC) Program – 11 new and eight renewed appointments.  

Prix du Québec honours for Nathalie Tufenkji

McGill environmental engineer who focuses on ‘problems that matter outside the lab’ recognized for research on plastic pollution  By Neale McDevitt

'Heart-in-a-dish' paves way for personalized treatment for heart failure

McGill researchers have developed a new way to study why the same heart-failure treatment can help some patients recover while others continue to get worse.

Combining “heart-in-a-dish” technology with advanced microscopy, the approach makes it possible to identify differences between patients that would probably be missed using conventional methods.

Day in the Lab: Inspiring Girls Through Science

Last week, D2R accompanied high school girls in Grades 7-9 from Les Scientifines on a visit to the Biomedical Engineering Lab of D2R-funded researcher Caroline Wagner at McGill University. The visit offered students a firsthand look at the exciting world of science. 

McGill Hearing Screening

No appointment needed.

First come, first serve.

Thank you

Lawrence Kazak awarded NSERC’s Arthur B. McDonald Fellowship

McGill researcher at the forefront of metabolic science recognized with $250,000 award for promising early-career scientists

New treatment approach shows promise in reducing prostate cancer spread

Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an international Phase 3 trial.

New approach aims to make personalized RNA therapies accessible to more children with rare genetic brain disorders

Montreal, October 23, 2026 – For families of children with rare genetic neurodevelopmental disorders, receiving a diagnosis can provide an explanation for their child’s condition, but often offers few treatment options.

Researchers at McGill University are working to change that.

Several schizophrenia symptoms linked to a single brain signal

A single brain signal may help explain a range of seemingly unrelated schizophrenia symptoms, a new study has found.

Schizophrenia is often described as a list of separate problems. People may perceive the world differently, act on their surroundings differently, or speak in ways that are hard to follow.

Discovery could help predict which early breast cancers will spread

Immune cells that normally protect the body from infection can also drive the progression of some early breast cancers, McGill University researchers have found.

The discovery points to a potential way of distinguishing relatively harmless cases of ductal carcinoma in situ (DCIS) from those most likely to become invasive, one of the biggest challenges in breast cancer care.

What makes us human? A first atlas of functional DNA changes offers new clues

A new genetic atlas is helping scientists trace the DNA changes that transformed a shared primate ancestor into modern humans.

For the first time, researchers can systematically test which genetic differences between humans and chimpanzees affect gene activity.

Charles Couturier wins Marathon of Hope Clinician-Scientist Award for brain tumour research

2026 Marathon of Hope Clinician-Scientist Award will support research into overcoming immune resistance to brain tumour treatment

Survival mechanism in the brain may help explain PTSD

A surprising feature of how the brain stores memories could help explain why harmless situations can sometimes quickly feel threatening, a hallmark of anxiety and trauma disorders.

Scientists have long believed that fear helps the brain draw a clearer line between danger and safety. The new study from researchers at the Douglas Research Centre at McGill University and the University of Toronto-Scarborough, published in Nature Neuroscience, suggests the opposite.

Pain peaks earlier in life than might have been expected, global study finds

People experience the steepest increases in pain before age 55, rather than in later life as might be expected, a new study led by McGill University researchers has found.

Published in Nature Medicine, the study analyzed self-reported pain data from more than 6.1 million people across 118 countries and territories.